Transcription of AACE COMPREHENSIVE TYPE 2 DIABETES 2 0
{{id}} {{{paragraph}}}
COPYRIGHT 2020 AACE | MAY NOT BE REPRODUCED IN ANY FORM WITHOUT EXPRESS WRITTEN PERMISSION FROM AACE. | DOI ASSOCIATION OF CLINICAL ENDOCRINOLOGYAACE COMPREHENSIVETYPE 2 DIABETESMANAGEMENT ALGORITHMCOPYRIGHT 2020 AACE | MAY NOT BE REPRODUCED IN ANY FORM WITHOUT EXPRESS WRITTEN PERMISSION FROM AACE. | DOI 2020 AACE | MAY NOT BE REPRODUCED IN ANY FORM WITHOUT EXPRESS WRITTEN PERMISSION FROM AACE. | DOI for Treatment of Type 2 Model for Care of the Patient with Risk Factor of Antihyperglycemic MedicationsTABLE OF CONTENTSCOMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHMCOPYRIGHT 2020 AACE | MAY NOT BE REPRODUCED IN ANY FORM WITHOUT EXPRESS WRITTEN PERMISSION FROM AACE. | DOI OF THE AACE/ACE COMPREHENSIVETYPE 2 DIABETES MANAGEMENT modification underlies all therapy ( , weight control, physical activity, sleep, etc.)
duration of diabetes, presence of comorbidities, diabetic complications, and hypoglycemia risk Fixed regimen: Increase TDD by 2 U Adjustable regimen: FBG >180 mg/dL: add 20% of TDD FBG 140 180 mg/dL: add 10% of TDD FBG 110 139 mg/dL: add 1 unit If hypoglycemia, reduce TDD by: BG <70 mg/dL: 10% 20%
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}